Study finds once-daily relugolix combination therapy reduces menstrual bleeding in women with uterine fibroids,with less bone mineral density loss than with monotherapy.
U.S. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later NSAIDs may cause rare kidney problems in unborn babies and/or low levels of amniotic fluid.
Allergan withdraws and recalls uterine fibroid drug ulipristal acetate in Canada due to rare cases of severe liver injury requiring liver transplantation